MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway
- 2 May 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 369 (2) , 781-787
- https://doi.org/10.1016/j.bbrc.2008.02.093
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK55003, DK56930, RO1AI42819)
This publication has 34 references indexed in Scilit:
- RACK1 Targets the Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway To Link Integrin Engagement with Focal Adhesion Disassembly and Cell MotilityMolecular and Cellular Biology, 2007
- PRR5, a Novel Component of mTOR Complex 2, Regulates Platelet-derived Growth Factor Receptor β Expression and SignalingJournal of Biological Chemistry, 2007
- Identification of Protor as a novel Rictor-binding component of mTOR complex-2Biochemical Journal, 2007
- Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activityGenes & Development, 2006
- Fibronectin Stimulates Non–Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal PathwaysCancer Research, 2006
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- β1/β3 integrin ligation is uncoupled from ERK1/ERK2 activation in cytotoxic T lymphocytesJournal of Leukocyte Biology, 2003
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002